IP Considerations Following FDA Announcement on Flexibility for Cell and Gene Therapies
Key Takeaways: Manufacturing processes of cell and gene therapies (CGTs) may remain fluid well into development and even after FDA approval, and therefore sponsors of CGTs may benefit from patent...
Knobbe Martens Provides IP Counsel to Masimo in Definitive Agreement To Be Acquired by Danaher
IRVINE, Calif., February 17, 2026 – Masimo Corporation, a leading global medical device innovator, today announced that it has entered into a definitive agreement pursuant to which Danaher Corporation will...
Knobbe Martens Advises Conformal Medical on Definitive Agreement To Be Acquired by W. L. Gore & Associates
IRVINE, Calif., January, 8, 2026 – W. L. Gore & Associates, Inc. (Gore) a global materials science company dedicated to transforming industries and improving lives, announced this week that it...